StockCall.com Provides Stock Research on Elan Corporation plc, Community Health Systems Inc., Alere Inc., Cubist Pharmaceuticals Inc., and Seattle Genetics Inc.
New York City, New York -- (May 31, 2013)
The U.S. healthcare sector has seen the emergence of two major developments in recent years. The first is the Affordable Care Act (ACA), which was upheld by the U.S. Supreme Court last year. The ACA is the biggest overhaul of the U.S. healthcare industry in decades. The other major trend to emerge in the healthcare sector has been increasing competition from generic drug makers. With patents on several blockbuster drugs set to expire over the next few years, competition from generic drug makers is expected to rise. On Thursday, May 30, 2013, shares in healthcare companies ended mostly higher, tracking gains in the broad market. The major movers in the sector included Elan Corporation Plc (ADR) (NYSE: ELN), Community Health Systems (NYSE: CYH), Alere Inc. (NYSE: ALR), Cubist Pharmaceuticals Inc. (NASDAQ: CBST), and Seattle Genetics Inc. (NASDAQ: SGEN).StockCall free coverage on ELN, CYH, ALR, CBST, and SGEN is available upon registration at
www.stockcall.com/register
Shares in Elan Corporation Plc moved higher on Thursday, tracking gains in the broader market. The company’s shares ended the day 0.73% higher at $12.50 after trading between $12.38 and $12.56. A total of 8.45 million shares were traded which is below the daily average volume of 8.83 million. So far this year, shares of ELN have grown over 22.40%, outperforming the S&P 500. The stock is currently trading 15.54% below its 52-week high.Download the free technical research on ELN by signing up at
www.StockCall.com/ELN053113.pdf
Community Health Systems’ stock rallied yesterday, extending its gains for the week. The company’s shares ended the day 5.12% higher at $46.62. A total of 1.67 million shares were exchanged in the price range of $44.33 and $47.09. The stock has gained over 7.80% so far this week. Shares of CYH are up more than 51.60% so far in 2013, outperforming the S&P 500. The stock has moved above its 50-day moving average as a result of the gains this week.Register now and get access to the free analysis on CYH at
www.StockCall.com/CYH053113.pdf
Shares in Alere Inc. rose sharply on Thursday, closing 1.85% higher at $25.84 after trading between $25.37 and $25.97. A total of 336,946 shares were traded which is less than half the daily average volume of 708,821. The company’s shares have been stiff resistance at around $26. The stock is also trading below its 50-day moving average. So far this year, it has grown over 39.60%, outperforming the broader market.Sign up and read the complimentary report on ALR at
www.StockCall.com/ALR053113.pdf
Cubist Pharmaceuticals Inc.’s stock also moved higher yesterday, closing at $55.99, up 1.28% from previous session’s closing price. A total of 746,857 shares were traded between $54.96 and $56.07. Shares of CBST are currently trading close to their 52-week high of $56.68. So far this year, the stock has grown over 33.10%, outperforming the S&P 500.The free report on CBST can be downloaded by signing up now at
www.StockCall.com/CBST053113.pdf
Shares in Seattle Genetics Inc. rose sharply on Thursday, closing 2.09% higher at $35.68 after trading between $34.74 and $35.79. Volume at the closing bell was 618,025, below its daily average volume of 758,338. So far this year, the company’s shares have gained nearly 54%, outperforming the S&P 500. However, despite the gains, the stock is still trading 8.51% below its 52-week high.Free report on SGEN can be accessed by registering at
www.StockCall.com/SGEN053113.pdf
About StockCall.com
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at
www.stockcall.com
Contact Person:
William T. Knight
Email: info@stockcall.com
Contact Number: (646) 396-9857 (9:00 am EST – 01:30 pm EST)